Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

EW

Edwards Lifesciences Corp

Apr 24 • 04:00PM ET

88.61

Dollar change +0.86
Percentage change 0.98	%

Healthcare • Medical Devices • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO IVV VUG IHI VHT IWF QUAL RSP VV

Index	S&P 500	P/E	38.50	EPS (ttm)	2.30	Insider Own	1.58%	Shs Outstand	601.10M	Perf Week	1.57%
Market Cap	53.28B	Forward P/E	28.61	EPS next Y	3.10	Insider Trans	-4.22%	Shs Float	591.80M	Perf Month	-4.88%
Income	1.40B	PEG	4.12	EPS next Q	0.64	Inst Own	82.63%	Short Float	1.75%	Perf Quarter	22.15%
Sales	6.00B	P/S	8.87	EPS this Y	9.72%	Inst Trans	-0.08%	Short Ratio	2.59	Perf Half Y	28.33%
Book/sh	11.06	P/B	8.01	EPS next Y	12.44%	ROA	15.89%	Short Interest	10.38M	Perf Year	-0.20%
Cash/sh	2.74	P/C	32.33	EPS next 5Y	9.34%	ROE	22.52%	52W Range	60.57 - 96.12	Perf YTD	16.21%
Dividend Est.	-	P/FCF	82.89	EPS past 5Y	15.35%	ROI	19.16%	52W High	-7.81%	Beta	1.09
Dividend TTM	-	Quick Ratio	2.40	Sales past 5Y	10.28%	Gross Margin	76.04%	52W Low	46.29%	ATR (14)	2.00
Dividend Ex-Date	-	Current Ratio	3.38	EPS Y/Y TTM	-6.00%	Oper. Margin	27.81%	RSI (14)	45.59	Volatility	1.67% 2.11%
Employees	19800	Debt/Eq	0.10	Sales Y/Y TTM	11.56%	Profit Margin	23.35%	Recom	2.16	Target Price	95.44
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	-5.72%	Payout	0.00%	Rel Volume	0.64	Prev Close	87.75
Sales Surprise	2.49%	EPS Surprise	0.42%	Sales Q/Q	13.78%	Earnings	Apr 25 AMC	Avg Volume	4.01M	Price	88.61
SMA20	-2.72%	SMA50	-1.56%	SMA200	12.56%	Trades		Volume	2,550,786	Change	0.98%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral
Nov-28-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$57
Sep-26-23	Upgrade	Oppenheimer	Perform → Outperform	$90
Jul-19-23	Initiated	Robert W. Baird	Outperform	$107
May-30-23	Resumed	Morgan Stanley	Overweight	$102
Mar-29-23	Initiated	UBS	Neutral	$84
Mar-08-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$97 → $78
Feb-06-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-31-23	Downgrade	Bernstein	Outperform → Underperform	$95 → $66
Jan-30-23	Downgrade	Piper Sandler	Overweight → Neutral	$95 → $80
Dec-06-22	Downgrade	Stifel	Buy → Hold	$95 → $75
Oct-28-22	Downgrade	Oppenheimer	Outperform → Perform
Oct-26-22	Initiated	Mizuho	Buy	$100
Oct-18-22	Initiated	Barclays	Overweight	$96
Oct-12-22	Initiated	Jefferies	Buy	$110
Jul-29-22	Downgrade	Canaccord Genuity	Buy → Hold	$115 → $106
Apr-13-22	Initiated	Truist	Buy	$145

Show Previous Ratings

Apr-23-24 06:14AM	Boston Scientific, Dexcom and Edwards next as earnings season rolls on (MedTech Dive)
Apr-22-24 09:16AM	Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-19-24 01:08AM	Spinoffs, sales and tuck-ins top medtech deal priorities: Moodys (MedTech Dive)
Apr-18-24 10:01AM	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:10AM	Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024 (Business Wire)
11:01AM	Loading…
Apr-17-24 11:01AM	Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings? (Zacks)
Apr-12-24 04:37AM	Abbotts Nadim Geloo on Triclips US launch, Edwards competition (MedTech Dive)
Apr-07-24 04:30PM	Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It (Business Wire)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 09:40AM	Are Medical Stocks Lagging Edwards Lifesciences (EW) This Year? (Zacks)
Mar-19-24 02:24PM	Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark (Investor's Business Daily)
01:38PM	Edwards Lifesciences (EW) Up 21.8% YTD: What's Driving It? (Zacks)
Mar-15-24 04:02PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:50AM	Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It? (Zacks)
Mar-13-24 11:57AM	Edwards Lifesciences' (EW) SAPIEN TAVR Study Outcome Favorable (Zacks)
02:00PM	Loading…
Mar-11-24 02:00PM	Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR (Business Wire)
Mar-07-24 04:57PM	S&P 500 Gains and Losses Today: Index Notches Record Close Ahead of Jobs Report (Investopedia) +6.20%
11:31AM	Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-06-24 09:43AM	Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth (Zacks)
Feb-26-24 11:54AM	Here's Why You Should Buy Edward Lifesciences (EW) Stock Now (Zacks)
Feb-23-24 07:05AM	Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference (Business Wire)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
Feb-15-24 09:36AM	Edwards (EW) Gains From Balanced Core Growth and New Launches (Zacks)
Feb-13-24 12:09AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
Feb-09-24 02:21AM	Edwards Lifesciences Corp Director Heisz Stone Sells 7,056 Shares (GuruFocus.com)
Feb-07-24 04:11PM	Edwards Lifesciences' Fortunes Are Reaccelerating, Analyst Says But Its Stock Isn't (Investor's Business Daily)
11:19AM	Edwards Lifesciences Corporation (NYSE:EW) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:31AM	Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip (Zacks)
09:06AM	Q4 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
05:54AM	How Edwards Evoque valve won an early nod from the FDA (MedTech Dive)
07:55PM	Loading…
Feb-06-24 07:55PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Edwards Lifesciences (EW) Q4 Earnings Match Estimates (Zacks)
04:54PM	Edwards Lifesciences Corp (EW) Reports Robust Q4 and Full-Year 2023 Financial Results (GuruFocus.com)
04:44PM	Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat (Investor's Business Daily)
04:40PM	Edwards Lifesciences: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
07:18AM	Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System (Zacks)
Feb-02-24 07:00AM	Edwards EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve (Business Wire) +9.38%
06:27AM	Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment (MedTech Dive)
Feb-01-24 09:15AM	Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:44AM	Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength? (Zacks)
Jan-30-24 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024 (Business Wire)
06:15AM	4 heart device trends shaping the medtech sector in 2024 (MedTech Dive)
Jan-23-24 07:07AM	Edwards risks TAVR market share slip amid challenges from Abbott, Boston Scientific: survey (MedTech Dive)
Jan-19-24 11:26AM	What's in Store for Edwards Lifesciences (EW) in Q4 Earnings? (Zacks)
Jan-16-24 01:20AM	Edwards Lifesciences Corporation (EW) Fell in Q4 Despite Double-Digit Revenue Growth (Insider Monkey)
Jan-03-24 07:40AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Jan-02-24 09:00AM	Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-23 05:24AM	Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3 (Insider Monkey)
Dec-14-23 07:49PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
Dec-11-23 12:27PM	Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook (Zacks)
Dec-08-23 05:11AM	Edwards to spin off its critical care business (MedTech Dive)
Dec-07-23 05:00PM	S&P 500 Gains and Losses Today: AI Excitement Powers AMD, Alphabet (Investopedia)
08:30AM	Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference (Business Wire)
Nov-26-23 05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-25-23 06:58AM	Could Ozempic Harm These 3 Medical Device Stocks? (Motley Fool)
Nov-24-23 11:31AM	Edwards Lifesciences (EW) Up 6.8% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-23-23 06:06AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Oct-30-23 11:40AM	ITGR or EW: Which Is the Better Value Stock Right Now? (Zacks)
Oct-27-23 07:30AM	DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook (Zacks)
Oct-26-23 06:15PM	Why Edwards Lifesciences Stock Plummeted Today (Motley Fool) -8.14%
03:06PM	CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION (PR Newswire)
02:00PM	TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION (PR Newswire)
11:33AM	Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:17AM	Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip (Zacks)
11:12AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:08AM	CONMED (CNMD) Beats on Q3 Earnings, Ups '23 EPS View (Zacks)
07:23AM	Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)
07:20AM	Q3 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-25-23 06:00PM	Edwards Lifesciences Corp (EW) Reports Q3 Earnings: Sales Growth and New Therapy Approvals (GuruFocus.com)
06:00PM	Edwards Lifesciences (EW) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:40PM	Edwards Lifesciences (EW) Q3 Earnings Match Estimates (Zacks)
04:32PM	Edwards Lifesciences: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences quarterly sales jump on robust demand for heart devices (Reuters)
04:15PM	EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS (PR Newswire)
10:08AM	Medical Device Stocks' Q3 Earnings Due on Oct 26: BSX, BIO & More (Zacks)
06:22AM	5 Large-Cap Stocks to Buy Ahead of Q3 Earnings This Week (Zacks)
Oct-24-23 02:00PM	FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE (PR Newswire)
Oct-23-23 03:58AM	What's in Store for Edwards Lifesciences (EW) in Q3 Earnings? (Zacks)
02:18AM	Edwards Lifesciences Corporation (EW) Declined Despite Double-Digit Revenue Growth (Insider Monkey)
Oct-20-23 11:47AM	What's in Store for Option Care Health (OPCH) in Q3 Earnings? (Zacks)
Oct-19-23 10:01AM	Teleflex (TFX) to Report Q3 Results: What to Know Ahead of the Release (Zacks)
08:30AM	EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARK (PR Newswire)
06:54AM	4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates (Zacks)
Oct-18-23 12:10PM	Why Edwards Lifesciences (EW) Could Beat Earnings Estimates Again (Zacks)
07:05AM	EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023 (PR Newswire)
Oct-17-23 04:15PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
02:01PM	MedTech Earnings in the Age of Ozempic May Not Be That Bad (Barrons.com)
08:07AM	Here's Why You Should Buy Edward Lifesciences (EW) Stock Now (Zacks)
Oct-12-23 11:40AM	ITGR vs. EW: Which Stock Is the Better Value Option? (Zacks)
Oct-10-23 12:06PM	Edwards Lifesciences Corp (EW): A Deep Dive into its Financial Growth and Competitive Edge (GuruFocus.com)
11:33AM	Unveiling Edwards Lifesciences (EW)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Oct-05-23 12:03PM	Edwards Lifesciences Corp (EW): A Deep Dive into Financial Metrics and Competitive Strengths (GuruFocus.com)
Sep-26-23 12:04PM	Edwards Lifesciences Corp (EW): A Deep Dive into Financial Metrics and Competitive Strengths (GuruFocus.com)
11:37AM	Edwards Lifesciences (EW): A Deep Dive into Its Significant Undervaluation (GuruFocus.com)
10:09AM	DraftKings upgraded, Snap initiated at Sell: Wall Street's top analyst calls (The Fly)
Sep-21-23 07:49PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
11:40AM	ITGR or EW: Which Is the Better Value Stock Right Now? (Zacks)
Sep-20-23 12:08PM	Edwards Lifesciences Corp (EW): A Deep Dive into Its Financial Metrics and Competitive Strengths (GuruFocus.com)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Option Exercise	36.75	857	31,495	18,345	Apr 09 05:33 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Sale	92.34	857	79,135	17,488	Apr 09 05:33 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Option Exercise	36.75	14,400	529,200	188,249	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Option Exercise	36.75	12,500	459,375	52,268	Apr 08 05:10 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Sale	92.32	14,400	1,329,472	173,849	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Sale	92.33	12,500	1,154,142	39,768	Apr 08 05:10 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Apr 04 06:26 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Sale	92.42	29,350	2,712,418	4,486	Apr 04 06:26 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Option Exercise	36.75	7,255	266,621	26,329	Apr 01 06:55 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Sale	94.89	7,255	688,423	19,074	Apr 01 06:55 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Option Exercise	36.75	14,500	532,875	54,003	Mar 13 05:44 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Sale	91.01	14,500	1,319,696	39,503	Mar 13 05:44 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Option Exercise	36.75	14,400	529,200	187,984	Mar 11 06:00 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Sale	91.68	14,400	1,320,149	173,584	Mar 11 06:00 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Option Exercise	36.75	1,715	63,026	18,928	Mar 07 06:22 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Sale	90.98	1,715	156,031	17,213	Mar 07 06:22 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Mar 04 07:16 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Sale	86.67	29,350	2,543,737	4,486	Mar 04 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Option Exercise	36.75	7,255	266,621	26,329	Feb 29 05:12 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Sale	85.59	7,255	620,923	19,074	Feb 29 05:12 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Option Exercise	36.86	7,056	260,107	10,757	Feb 26 05:52 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Sale	87.61	3,058	267,911	67,219	Feb 26 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Option Exercise	59.26	7,000	414,797	30,950	Feb 21 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Sale	86.74	8,200	711,272	22,750	Feb 21 05:52 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Option Exercise	36.75	27,000	992,250	61,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Sale	85.62	27,000	2,311,654	34,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Option Exercise	36.75	20,000	735,000	54,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Option Exercise	36.75	11,000	404,250	50,503	Feb 13 04:51 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Sale	86.46	20,000	1,729,200	34,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Sale	85.83	11,000	944,155	39,503	Feb 13 04:51 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Option Exercise	36.75	12,210	448,718	25,297	Feb 12 05:44 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Sale	87.00	12,210	1,062,270	13,087	Feb 12 05:44 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Option Exercise	36.86	7,056	260,107	34,036	Feb 08 06:08 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Sale	86.45	7,056	609,991	26,980	Feb 08 06:08 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Feb 05 06:37 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Sale	87.49	29,350	2,567,754	4,486	Feb 05 06:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Option Exercise	36.75	7,255	266,621	26,503	Feb 01 05:52 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Sale	78.29	7,255	567,994	19,248	Feb 01 05:52 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Option Exercise	36.75	10,000	367,500	49,503	Jan 12 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Sale	75.67	10,000	756,700	39,503	Jan 12 05:36 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Jan 05 07:19 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Sale	72.98	29,350	2,142,089	4,486	Jan 05 07:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Option Exercise	36.75	14,510	533,242	33,758	Dec 29 04:25 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Sale	76.55	14,510	1,110,794	19,248	Dec 29 04:25 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Option Exercise	59.26	7,000	414,797	30,950	Dec 15 05:22 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Sale	78.25	7,000	547,724	23,950	Dec 15 05:22 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Option Exercise	45.28	8,658	392,006	222,452	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Option Exercise	36.75	8,000	294,000	47,503	Dec 13 07:04 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Sale	74.62	29,350	2,190,043	4,486	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Sale	71.86	8,658	622,164	213,794	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Sale	71.86	8,000	574,880	39,503	Dec 13 07:04 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Option Exercise	59.26	3,500	207,398	27,450	Dec 06 05:01 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Sale	70.00	3,500	245,006	23,950	Dec 06 05:01 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Option Exercise	36.75	6,000	220,500	45,503	Nov 13 05:21 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Sale	65.30	8,660	565,460	213,794	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Sale	65.30	6,000	391,780	39,503	Nov 13 05:21 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Nov 06 06:33 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Sale	67.18	29,350	1,971,733	4,486	Nov 06 06:33 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Oct 31 05:22 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Sale	62.66	7,255	454,569	19,248	Oct 31 05:22 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Option Exercise	36.75	5,000	183,750	44,503	Oct 13 05:01 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Sale	70.00	8,660	606,198	213,794	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Sale	69.98	5,000	349,909	39,503	Oct 13 05:01 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Option Exercise	36.75	5,000	183,750	39,814	Oct 10 06:23 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Sale	72.68	5,000	363,400	34,814	Oct 10 06:23 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Option Exercise	59.26	8,500	503,682	32,450	Oct 03 04:58 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Sale	70.00	8,500	595,000	23,950	Oct 03 04:58 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Oct 02 06:51 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Sale	68.84	29,350	2,020,454	4,486	Oct 02 06:51 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Option Exercise	36.75	7,255	266,621	26,503	Sep 29 04:49 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Sale	69.54	7,255	504,527	19,248	Sep 29 04:49 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Option Exercise	45.28	8,660	392,096	222,454	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Sep 14 08:00 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Sale	73.63	8,660	637,615	213,794	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Sale	73.71	4,500	331,695	39,503	Sep 14 08:00 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Option Exercise	36.75	5,000	183,750	39,814	Sep 08 05:29 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Sale	76.00	5,000	380,000	34,814	Sep 08 05:29 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Option Exercise	59.26	8,500	503,682	32,450	Sep 06 05:09 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Sale	76.07	8,500	646,609	23,950	Sep 06 05:09 PM
MUSSALLEM MICHAEL A	Director	Sep 05 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Sep 05 07:08 PM
MUSSALLEM MICHAEL A	Director	Sep 05 '23	Sale	75.86	29,350	2,226,491	4,486	Sep 05 07:08 PM
Ullem Scott B.	CVP, Chief Financial Officer	Aug 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Aug 31 05:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	Aug 31 '23	Sale	77.79	7,255	564,366	19,248	Aug 31 05:34 PM
Chopra Daveen	CVP, TMTT	Aug 29 '23	Sale	76.69	1,500	115,040	23,950	Aug 29 05:31 PM
Wood Larry L	Global President TAVR & Surg	Aug 14 '23	Option Exercise	45.28	6,421	290,722	220,215	Aug 14 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Aug 14 06:02 PM
Wood Larry L	Global President TAVR & Surg	Aug 14 '23	Sale	79.30	6,421	509,185	213,794	Aug 14 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '23	Sale	79.30	4,500	356,850	39,503	Aug 14 06:02 PM
STONE HEISZ LESLIE	Director	Aug 10 '23	Sale	78.87	3,303	260,509	26,980	Aug 10 05:48 PM
Szyman Catherine M.	CVP, Critical Care	Aug 09 '23	Option Exercise	36.75	5,000	183,750	39,814	Aug 09 05:44 PM
Szyman Catherine M.	CVP, Critical Care	Aug 09 '23	Sale	78.64	5,000	393,185	34,814	Aug 09 05:44 PM
MUSSALLEM MICHAEL A	Director	Aug 07 '23	Option Exercise	36.75	29,350	1,078,612	83,602	Aug 07 07:20 PM
MUSSALLEM MICHAEL A	Director	Aug 07 '23	Sale	79.87	29,350	2,344,095	54,252	Aug 07 07:20 PM
Ullem Scott B.	CVP, Chief Financial Officer	Jul 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Jul 31 05:23 PM
Ullem Scott B.	CVP, Chief Financial Officer	Jul 31 '23	Sale	84.35	7,255	611,959	19,248	Jul 31 05:23 PM
Wood Larry L	Global President TAVR & Surg	Jul 14 '23	Option Exercise	45.28	8,660	392,096	222,454	Jul 14 05:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jul 14 '23	Option Exercise	36.75	3,500	128,625	43,003	Jul 14 05:58 PM

Open in Screener

NARI

Inari Medical Inc

Apr 24 • 04:00PM ET

38.18

Dollar change +1.07
Percentage change 2.88	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

NARI Inari Medical Inc daily Stock Chart

Held by: IJR VTI VB IWM VXF VBK IWO IHI IJT IJS

Index	RUT	P/E	-	EPS (ttm)	-0.03	Insider Own	14.45%	Shs Outstand	57.76M	Perf Week	-1.34%
Market Cap	2.21B	Forward P/E	192.98	EPS next Y	0.20	Insider Trans	-1.45%	Shs Float	49.59M	Perf Month	-9.93%
Income	-1.64M	PEG	-	EPS next Q	-0.16	Inst Own	87.07%	Short Float	8.05%	Perf Quarter	-32.14%
Sales	493.63M	P/S	4.48	EPS this Y	-1339.10%	Inst Trans	0.07%	Short Ratio	3.33	Perf Half Y	-33.54%
Book/sh	8.05	P/B	4.74	EPS next Y	145.82%	ROA	-0.28%	Short Interest	3.99M	Perf Year	-45.28%
Cash/sh	2.00	P/C	19.07	EPS next 5Y	-	ROE	-0.37%	52W Range	36.73 - 71.85	Perf YTD	-41.19%
Dividend Est.	-	P/FCF	70.88	EPS past 5Y	32.83%	ROI	-0.33%	52W High	-46.86%	Beta	0.93
Dividend TTM	-	Quick Ratio	2.52	Sales past 5Y	197.48%	Gross Margin	87.12%	52W Low	3.95%	ATR (14)	1.84
Dividend Ex-Date	-	Current Ratio	3.09	EPS Y/Y TTM	94.57%	Oper. Margin	-1.28%	RSI (14)	33.49	Volatility	4.39% 4.28%
Employees	1300	Debt/Eq	0.07	Sales Y/Y TTM	28.73%	Profit Margin	-0.33%	Recom	1.45	Target Price	72.09
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	25.14%	Payout	-	Rel Volume	1.14	Prev Close	37.11
Sales Surprise	0.23%	EPS Surprise	-1411.48%	Sales Q/Q	22.57%	Earnings	Apr 30 AMC	Avg Volume	1.20M	Price	38.18
SMA20	-9.46%	SMA50	-17.46%	SMA200	-33.58%	Trades		Volume	1,369,885	Change	2.88%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-29-24	Downgrade	Piper Sandler	Overweight → Neutral	$85 → $55
Jan-23-24	Initiated	Needham	Buy	$72
Jul-19-23	Initiated	Robert W. Baird	Outperform	$79
Oct-12-22	Initiated	Jefferies	Buy	$88
Sep-29-22	Initiated	Berenberg	Buy	$85
Sep-13-22	Initiated	Truist	Hold	$87
Jun-21-22	Initiated	Piper Sandler	Overweight	$100
Mar-23-22	Resumed	BofA Securities	Buy	$105
Dec-15-20	Upgrade	Wells Fargo	Equal Weight → Overweight	$79
Nov-18-20	Initiated	BTIG Research	Buy	$92
Oct-29-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$66 → $76
Sep-28-20	Initiated	SVB Leerink	Outperform	$80
Jun-19-20	Initiated	Canaccord Genuity	Buy
Jun-16-20	Initiated	Wells Fargo	Equal Weight	$49
Jun-16-20	Initiated	Morgan Stanley	Equal-Weight	$52
Jun-16-20	Initiated	BofA/Merrill	Neutral	$56

Show Previous Ratings

Apr-22-24 10:26AM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
Apr-19-24 10:09AM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
Apr-18-24 01:25PM	Inari Medical, Inc. (NARI) Downgraded by Analysts Due to Pending DOJ Probe Hagens Berman (GlobeNewswire)
Apr-17-24 04:05PM	Inari Medical to Announce First Quarter 2024 Financial Results (GlobeNewswire)
Apr-15-24 10:52AM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
04:05PM	Loading…
Apr-11-24 04:05PM	Inari Medical Announces the Release of 2023 Ethos and Sustainability Report (GlobeNewswire)
03:33PM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
Apr-09-24 11:04AM	Why You Should Retain Inari Medical (NARI) Stock for Now (Zacks)
Apr-02-24 04:05PM	Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives (GlobeNewswire)
Mar-29-24 11:30AM	Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-25-24 06:15PM	AppFolio Set to Join S&P MidCap 400; Inari Medical to Join S&P SmallCap 600 (PR Newswire)
Mar-20-24 07:01PM	Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI) (GuruFocus.com)
Mar-14-24 10:45AM	Inari Medical's (NARI) ClotTriever Improves Patient Outcome (Zacks)
Mar-12-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm (GlobeNewswire)
04:05PM	Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry (GlobeNewswire)
11:30PM	Loading…
Mar-08-24 11:30PM	Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm (GlobeNewswire)
Mar-07-24 10:44AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Feb-29-24 03:37PM	Inari Medical Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire) -20.84%
11:32AM	Inari Medical (NARI) Q4 Earnings Improve Y/Y, Gross Margin Down (Zacks)
11:16AM	Inari Medical, Inc. (NASDAQ:NARI) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:43AM	Q4 2023 Inari Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 04:37PM	Inari Medical Inc (NARI) Reports Growth Amidst Operating Losses in Q4 2023 (GuruFocus.com)
04:05PM	Inari Medical Reports Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-14-24 04:05PM	Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-23-24 07:16AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Jan-15-24 03:13AM	Is Inari Medical (NARI) a Worthy Investment? (Insider Monkey)
Jan-12-24 12:16PM	Inari (NARI) Preliminary Q4 Revenues Ride on Procedure Demand (Zacks)
Jan-09-24 06:30AM	Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance (GlobeNewswire) -10.08%
Jan-08-24 09:00AM	OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER (PR Newswire)
Dec-20-23 04:01PM	Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
07:24AM	Loading…
Dec-15-23 07:24AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Dec-01-23 11:31AM	Inari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-30-23 11:19AM	Inari Medical's (NARI) PEERLESS II RCT to Boost Patient Outcome (Zacks)
Nov-27-23 04:20PM	Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT) (GlobeNewswire)
Nov-18-23 07:03AM	Insider Sell Alert: Director William Hoffman Sells 25,000 Shares of Inari Medical Inc (NARI) (GuruFocus.com)
Nov-15-23 04:05PM	Inari Medical Closes Acquisition of LimFlow (GlobeNewswire)
07:59AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Nov-06-23 09:35AM	Inari Medical, Inc. (NARI) Loses -27.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +8.80%
Nov-03-23 12:27PM	Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates (Zacks) -5.28%
10:59AM	Teleflex (TFX) Q3 Earnings Top Estimates, 2023 Outlook Up (Zacks)
10:31AM	Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up (Zacks)
08:59AM	Penumbra (PEN) Q3 Earnings Top Estimates, Margins Increase (Zacks)
07:01AM	Inari Medical to buy limb-saving device maker LimFlow for up to $415M (MedTech Dive)
Nov-02-23 07:16PM	Inari Medical, Inc. (NASDAQ:NARI) Q3 2023 Earnings Call Transcript (Insider Monkey) -16.97%
04:01PM	Inari Medical to Present at Upcoming Investor Conferences (GlobeNewswire)
11:03AM	Exact Sciences (EXAS) Q3 Earnings Beat, Gross Margin Rises (Zacks)
11:02AM	Q3 2023 Inari Medical Inc Earnings Call (Thomson Reuters StreetEvents)
10:24AM	Envista (NVST) Q3 Earnings Miss Estimates, Gross Margin Down (Zacks)
Nov-01-23 06:54PM	Inari Medical Inc (NARI) Reports Q3 2023 Earnings: Revenue Up 31.4%, Net Income of $3.2 Million (GuruFocus.com)
05:01PM	LimFlow Announces Agreement to Be Acquired by Inari Medical (Business Wire)
04:02PM	Inari Medical Reports Third Quarter 2023 Financial Results (GlobeNewswire)
04:01PM	Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow (GlobeNewswire)
11:07AM	CVS Health (CVS) Q3 Earnings Surpass Estimates, Margins Up (Zacks)
09:53AM	IDEXX (IDXX) Q3 Earnings Top Estimates, '23 Sales View Down (Zacks)
Oct-31-23 07:37AM	QIAGEN (QGEN) Q3 Earnings and Revenues Beat, Margins Down (Zacks)
07:33AM	Medical Device Stocks to Watch for Earnings on Nov 1: MCK & More (Zacks)
Oct-30-23 09:48AM	Zacks Industry Outlook Highlights Alcon, STERIS and Inari Medical (Zacks)
Oct-27-23 10:12AM	3 Medical Instruments Stocks Countering Industry-Wide Headwinds (Zacks)
08:08AM	Chemed (CHE) Q3 Earnings and Revenues Surpass, Margins Rise (Zacks)
08:01AM	ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down (Zacks)
Oct-26-23 10:36AM	Labcorp (LH) Q3 Earnings and Revenues Beat, Margins Fall (Zacks)
07:14AM	Align Technology (ALGN) Q3 Earnings Miss, Operating Margin Up (Zacks)
Oct-18-23 10:23PM	Director William Hoffman Sells 25,000 Shares of Inari Medical Inc (GuruFocus.com)
06:12AM	3 Solid Stocks to Buy for Superb Earnings Acceleration (Zacks)
Oct-11-23 04:01PM	Inari Medical to Announce Third Quarter 2023 Financial Results (GlobeNewswire) -12.29%
12:08PM	Unraveling the Future of Inari Medical Inc (NARI): A Deep Dive into Key Metrics (GuruFocus.com)
Oct-06-23 08:43AM	Reasons to Add Inari Medical (NARI) Stock to Your Portfolio (Zacks)
Sep-14-23 07:03PM	CFO Mitch Hill Sells 6,500 Shares of Inari Medical Inc (GuruFocus.com)
Aug-24-23 04:01PM	Inari Medical to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-10-23 09:55AM	Wall Street Analysts See a 36.39% Upside in Inari Medical, Inc. (NARI): Can the Stock Really Move This High? (Zacks) +5.92%
Aug-08-23 01:26PM	Shockwave Medical (SWAV) Q2 Earnings Miss, Revenues Surge Y/Y (Zacks) -5.24%
Aug-06-23 08:56AM	Is Inari Medical, Inc. (NASDAQ:NARI) Expensive For A Reason? A Look At Its Intrinsic Value (Simply Wall St.)
Aug-05-23 05:21AM	2 Top Healthcare Stocks I'd Buy Now Without Hesitation (Motley Fool)
Aug-04-23 08:59AM	Inari Medical (NARI) Q2 Earnings Top, Revenues Rise Y/Y (Zacks)
Aug-03-23 02:26PM	Why Shares of Inari Medical Are Up Thursday (Motley Fool) +21.64%
Aug-02-23 05:25PM	Inari Medical, Inc. (NARI) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:01PM	Inari Medical Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:01PM	Inari Medical to Present at the 43rd Annual Canaccord Growth Conference (GlobeNewswire)
Jul-20-23 07:09AM	Should You Think About Buying Inari Medical, Inc. (NASDAQ:NARI) Now? (Simply Wall St.)
Jul-13-23 04:01PM	Inari Medical to Announce Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-04-23 07:19AM	Reasons to Add Inari Medical (NARI) Stock to Your Portfolio (Zacks)
Jun-21-23 08:00PM	NARI: What does Argus have to say about NARI? (Argus Research)
Jun-12-23 07:13AM	Inari Medical (NASDAQ:NARI) shareholders have earned a 7.4% CAGR over the last three years (Simply Wall St.)
Jun-08-23 11:13AM	Inari Medical (NARI) Launches New Catheters to Address VTE (Zacks)
Jun-07-23 08:00AM	Inari Medical Announces Commercial Launch of RevCore and Triever16 Curve, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism (GlobeNewswire)
Jun-02-23 11:31AM	Inari Medical, Inc. (NARI) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
May-25-23 04:01PM	Inari Medical Announces the Release of 2022 Ethos and Sustainability Report (GlobeNewswire)
May-22-23 08:00AM	Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients (GlobeNewswire)
06:28AM	Here's Why You Should Retain Inari Medical (NARI) Stock Now (Zacks)
May-15-23 10:16AM	Companies Like Inari Medical (NASDAQ:NARI) Are In A Position To Invest In Growth (Simply Wall St.)
09:55AM	Wall Street Analysts Think Inari Medical, Inc. (NARI) Could Surge 27.7%: Read This Before Placing a Bet (Zacks)
May-04-23 07:31AM	Inari Medical (NARI) Q1 Earnings Top, Revenues Rise Y/Y (Zacks)
May-03-23 05:15PM	Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Inari Medical Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-02-23 04:01PM	Inari Medical to Present at the Bank of America 2023 Healthcare Conference (GlobeNewswire) -5.99%
Apr-26-23 08:00PM	NARI: What does Argus have to say about NARI? (Argus Research)
Apr-18-23 10:05AM	Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues (Simply Wall St.)
Apr-13-23 04:01PM	Inari Medical to Announce First Quarter 2023 Financial Results (GlobeNewswire)
Apr-05-23 10:52AM	Here's Why You Should Retain Inari Medical (NARI) Stock Now (Zacks)
Mar-16-23 03:29PM	Why Shares of Inari Medical Rose This Week (Motley Fool)

Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoffman William	Director	Apr 16 '24	Sale	40.00	1,451	58,040	999,782	Apr 18 06:38 PM
Hill, Mitch C.	Chief Financial Officer	Apr 12 '24	Option Exercise	0.46	6,000	2,742	187,294	Apr 16 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Apr 12 '24	Sale	40.96	6,000	245,760	181,294	Apr 16 04:32 PM
Hoffman William	Director	Mar 18 '24	Sale	41.13	40,000	1,645,079	1,003,296	Mar 20 04:34 PM
Hill, Mitch C.	Chief Financial Officer	Mar 12 '24	Option Exercise	0.46	6,000	2,742	189,361	Mar 14 04:31 PM
Hill, Mitch C.	Chief Financial Officer	Mar 12 '24	Sale	41.91	6,000	251,461	183,361	Mar 14 04:31 PM
Hoffman William	Director	Dec 15 '23	Sale	65.08	25,000	1,627,073	1,045,493	Dec 19 05:18 PM
Hill, Mitch C.	Chief Financial Officer	Dec 12 '23	Option Exercise	0.46	6,500	2,970	176,730	Dec 14 04:35 PM
Hill, Mitch C.	Chief Financial Officer	Dec 12 '23	Sale	62.75	6,500	407,855	170,230	Dec 14 04:35 PM
Hoffman William	Director	Dec 04 '23	Option Exercise	0.43	103,492	44,336	1,070,493	Dec 06 05:07 PM
Hykes Andrew	President and CEO	Nov 16 '23	Sale	59.82	37,448	2,240,277	434,817	Nov 17 07:17 PM
Tu Thomas	Chief Medical Officer	Nov 16 '23	Sale	59.82	25,451	1,522,573	320,932	Nov 17 07:19 PM
Hoffman William	Director	Nov 15 '23	Sale	61.24	25,000	1,531,124	967,001	Nov 17 06:27 PM
Hill, Mitch C.	Chief Financial Officer	Nov 13 '23	Option Exercise	0.46	6,500	2,970	176,730	Nov 15 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Nov 13 '23	Sale	56.06	6,500	364,366	170,230	Nov 15 04:32 PM
MILDER DONALD B	Director	Nov 08 '23	Buy	53.48	2,100	112,303	3,031,714	Nov 08 05:48 PM
MILDER DONALD B	Director	Nov 07 '23	Buy	53.44	54,000	2,885,760	3,029,614	Nov 08 05:48 PM
Hoffman William	Director	Oct 16 '23	Sale	57.28	25,000	1,432,098	992,001	Oct 18 05:39 PM
Hill, Mitch C.	Chief Financial Officer	Oct 12 '23	Option Exercise	0.46	6,500	2,970	176,730	Oct 16 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Oct 12 '23	Sale	55.74	6,500	362,340	170,230	Oct 16 04:32 PM
Hoffman William	Director	Sep 15 '23	Sale	66.74	25,000	1,668,503	1,023,055	Sep 19 04:38 PM
Hill, Mitch C.	Chief Financial Officer	Sep 12 '23	Option Exercise	0.46	6,500	2,970	178,302	Sep 14 04:41 PM
Hill, Mitch C.	Chief Financial Officer	Sep 12 '23	Sale	67.85	6,500	441,040	171,802	Sep 14 04:41 PM
Hykes Andrew	President and CEO	Aug 16 '23	Sale	66.11	36,676	2,424,829	475,132	Aug 18 05:05 PM
Tu Thomas	Chief Medical Officer	Aug 16 '23	Sale	66.11	24,926	1,647,980	347,997	Aug 18 05:01 PM
Hoffman William	Director	Aug 15 '23	Sale	69.02	25,000	1,725,537	1,048,055	Aug 17 04:46 PM
Hill, Mitch C.	Chief Financial Officer	Aug 14 '23	Option Exercise	0.46	6,500	2,970	178,302	Aug 16 04:46 PM
Hill, Mitch C.	Chief Financial Officer	Aug 14 '23	Sale	70.47	6,500	458,053	171,802	Aug 16 04:46 PM
Hoffman William	Director	Jul 17 '23	Sale	57.08	25,000	1,426,914	1,073,055	Jul 19 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Jul 12 '23	Option Exercise	0.46	6,500	2,970	177,982	Jul 14 04:35 PM
Hill, Mitch C.	Chief Financial Officer	Jul 12 '23	Sale	56.24	6,500	365,540	171,482	Jul 14 04:35 PM
Hoffman William	Director	Jun 15 '23	Sale	57.74	25,000	1,443,576	1,098,055	Jun 16 04:42 PM
Hill, Mitch C.	Chief Financial Officer	Jun 12 '23	Option Exercise	0.46	6,500	2,970	179,554	Jun 13 05:48 PM
Hill, Mitch C.	Chief Financial Officer	Jun 12 '23	Sale	59.24	6,500	385,088	173,054	Jun 13 05:48 PM
ROOT JONATHAN D	Director	May 27 '23	Option Exercise	0.00	2,982	0	537,023	May 30 04:37 PM
Nielsen Kirk G.	Director	May 27 '23	Option Exercise	0.00	2,982	0	61,479	May 30 04:35 PM
MILDER DONALD B	Director	May 27 '23	Option Exercise	0.00	2,982	0	255,000	May 30 04:38 PM
Hoffman William	Director	May 17 '23	Sale	69.19	41,891	2,898,438	1,120,643	May 18 08:18 PM
Hykes Andrew	President and CEO	May 17 '23	Sale	69.19	18,760	1,298,004	513,608	May 18 08:16 PM
Tu Thomas	Chief Medical Officer	May 17 '23	Sale	69.19	12,751	882,242	373,727	May 18 08:15 PM
Hoffman William	Director	May 16 '23	Sale	70.87	40,006	2,835,225	1,162,534	May 18 08:18 PM
Hykes Andrew	President and CEO	May 16 '23	Sale	70.87	17,916	1,269,707	532,368	May 18 08:16 PM
Tu Thomas	Chief Medical Officer	May 16 '23	Sale	70.87	12,176	862,913	386,478	May 18 08:15 PM
Hoffman William	Director	May 15 '23	Sale	70.51	25,000	1,762,860	1,202,540	May 18 08:18 PM
Hill, Mitch C.	Chief Financial Officer	May 12 '23	Option Exercise	0.46	6,500	2,970	185,804	May 16 05:41 PM
Hill, Mitch C.	Chief Financial Officer	May 12 '23	Sale	70.26	12,750	895,805	173,054	May 16 05:41 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

EW

Edwards Lifesciences Corp

NARI

Inari Medical Inc

Upgrade your FINVIZ experience